Prices are updated after-hours

Relief Therapeutics Holding SA

RLFTF | $1.45 11.45% 1.3K

(0.0% 1d) (-7.1% 1m) (7737.8% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-70.91% volume)
Earnings Calendar:
Market Cap: $ 20,359,214
http://www.relieftherapeutics.com
Sec Filling | Patents | n/a employees

(CH) RELIEF THERAPEUTICS Holding AG is a clinical stage biotechnology company. It engages in the development and licensing of its portfolio of medicinal products candidates. Its products include aviptadil, for respiratory indications such as sarcoidosis and pulmonary hypertension; and atexakin alfa, for the treatment of diabetic neuropathy. The company was founded in June 2016 and is headquartered in Geneva, Switzerland.

treatment respiratory diabetes diabetic

add to watch list Paper trade email alert is off

Relief Therapeutics Holding SA

RLFTY | $1.4006 733.33% 100

n/a

(0.0% 1d) (-2.1% 1m) (-65.0% 1y) (0.0% 2d) (0.0% 3d) (-2.1% 7d) (-75.0% volume)
Earnings Calendar:
Market Cap: $ 19,665,596
https://relieftherapeutics.com/c
Sec Filling | Patents | 3367 employees

(CH) aeris was founded with the aim of becoming a benchmark on the wind blade manufacturing and, to achieve this goal, has created a highly skilled team with the potential to add value and quality to the product and management and respond efficiently to the challenges of the market.

add to watch list Paper trade email alert is off